Xylitol, FTC Censorship, and the Oral–Heart Health Connection: Nathan Jones, CEO and founder of
Xlear, Inc., makers of xylitol-based nasal and
dental hygiene products, and a health freedom advocate, discusses Jones’ ongoing legal battle with the FTC. He addresses the difficulty of making health claims for hygiene products (including toothpaste and nasal sprays), the role of “weasel words” in supplement marketing, and concerns about regulatory double standards versus pharmaceuticals.
He also reviews xylitol’s benefits for dental caries and respiratory/ear infections, including references to studies and public-health examples (e.g., Finland and a Belize program reducing dental caries costs), and Jones’ efforts to encourage Utah to implement xylitol gum programs in schools. He contrasts fluoride’s enamel-strengthening approach with xylitol’s effect on the underlying bacterial cause of tooth decay, discusses Utah’s fluoride policy change and claims about fluoride’s limited benefit, and highlights a correlation between poor oral health and cardiovascular risk via inflammation and bacterial translocation into the bloodstream, including pathogens found in atherosclerotic plaque, and links also discussed for dementia and Parkinson’s.
They close with commentary on health advocacy in the “MAHA era,” the challenges of entrenched federal bureaucracy, and Jones’ preference for advocacy groups that teach industry to push back rather than comply.